{"id":206463,"name":"AEGLEA BIOTHERAPEUTICS, INC.","slug":"aeglea-biotherapeutics-inc","state":"TX","country":"United States of America","description":"Clinical-stage biotechnology company; designs and develops human enzyme therapeutics","totalSpending":330000,"filings":13,"yearlySpending":[{"year":2020,"income":80000},{"year":2021,"income":120000},{"year":2022,"income":100000},{"year":2023,"income":30000}],"issues":["PHA","HCR"],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON","KATHERINE LANDES","JACOB JACKSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) engagement","Meetings on Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) Engagement","H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019\n\nS.4010/H.R. 4439 - Creating Hope Reauthorization Act","Drug pricing","H.R. 1730/S. 670, STAT Act\nH.R. 482/S. 350, Newborn Screening Reauthorization Act\nCures 2.0 (not introduced)"],"years":[2020,2021,2022,2023]}